Use of Omeprazole in the Management of Reflux Oesophagitis Resistant to H₂-receptor Antagonists

References

• De Meester T R, Johnson L F, Joseph G J, Toscano M S, Hall A W, Skinner D B. Patterns of gastroesophageal reflux in health and disease. Ann Surg 1976; 184: 459–470
   PubMedGoogle Scholar
• Dodds W J, Hogan W J, Helm J F, Dent J. Pathogenesis of reflux esophagitis. Gastroenterology 1981; 81: 376–394
   PubMed Web of Science ®Google Scholar
• Castell D O. Gastroesophageal reflux disease, D O Castell, W C Wu, D J Ott. Futura, New York 1985; 221–241
   Google Scholar
• Tytgat G NJ, Nio C Y. The medical therapy of reflux oesophagitis. Baillieres Clin Gastroenterol 1987; 1: 791–807
   PubMedGoogle Scholar
• Richter J E. A critical review of current medical therapy for gastroesophageal reflux disease. J Clin Gastroenterol 1986; 8(suppl)72–80
   PubMedGoogle Scholar
• Wesdorp E, Bartelsman J, Pape K, Dekker W, Tytgat G N. Oral cimetidine in reflux esophagitis, a double blind controlled trial. Gastroenterology 1978; 74: 821–824
   PubMed Web of Science ®Google Scholar
• Lepsien G, Sonnenberg A, Berges W, et al. Die Behandlung der Refluxösophagitis mit Cimetidin. Dtsch Med Wochenschr 1979; 104: 901–906
   PubMed Web of Science ®Google Scholar
• Fiasse R, Hanin C, Lepot A, Descamps C, Lamy F, Dive C. Controlled trial of cimetidine in reflux esophagitis. Dig Dis Sci 1980; 25: 750–755
   PubMed Web of Science ®Google Scholar
• Wesdorp I CE, Dekker W, Klinkenberg-Knol E C. Treatment of reflux oesophagitis with ranitidine. Gut 1983; 24: 921–924
   PubMed Web of Science ®Google Scholar
• Koelz H R, Birchler A, Bretholz A, et al. Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology 1986; 91: 1198–1205
   PubMed Web of Science ®Google Scholar
• Johansson K-E, Tibbling L. Gastric secretion and reflux pattern in reflux oesophagitis before and during ranitidine treatment. Scand J Gastroenterol 1986; 21: 487–92
   PubMed Web of Science ®Google Scholar
• Desechalliers J P, Galmiche J P, Touchais J Y, Denis P, Colin R. Ranitidine, cimetidine, antacids and gastro-oesophageal reflux: results of a 20-hour oesophageal pH study. Int J Clin Pharmacol Res 1984; 4: 217–222
   PubMedGoogle Scholar
• Klinkenberg-Knol E C, Festen H PM, Meuwissen S GM. The effects of omeprazole and ranitidine on 24-hour pH in the distal oesophagus of patients with reflux oesophagitis. Aliment Pharmacol Ther 1988; 2: 221–227
   PubMed Web of Science ®Google Scholar
• Fellenius E, Berglindh T, Sachs G, et al. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase. Nature 1981; 290: 159–161
   PubMed Web of Science ®Google Scholar
• Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L. Effect of omeprazole - a gastric proton pump inhibitor - on pentagastrin stimulated acid secretion in man. Gut 1983; 24: 270–276
   PubMed Web of Science ®Google Scholar
• Sharma B K, Walt R P, Pounder R E, Gomes M, de F A, Wood E C, Logan L H. Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut 1984; 25: 957–964
   PubMed Web of Science ®Google Scholar
• Lanzon-Miller S, Pounder R E, Hamilton M R, et al. Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther 1987; 1: 239–252
   PubMedGoogle Scholar
• Bardhan K D, Bianchi Porro G, Bosel K, et al. A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol 1986; 8: 408–413
   PubMed Web of Science ®Google Scholar
• Klinkenberg-Knol E C, Jansen J MBJ, Festen H PMW, Meuwissen S GM, Lamers C BHW. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet 1987; i: 349–351
   Google Scholar
• Havelund T, Laursen L S, Skoubo-Kristensen E, et al. Omeprazole and ranitidine in treatment of reflux oesophagitis, double blind comparative trial. Br Med J 1988; 296: 89–92
   PubMed Web of Science ®Google Scholar
• Vantrappen G, Rutgeerts L, Schurmans P, Coene-Grachts J-L. Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis. Dig Dis Sci 1988; 33: 523–529
   PubMed Web of Science ®Google Scholar
• Lundell L, Fausa O, Sandmark S. London, The British Society of. Gastroenterology 1987; 108: TH16
   Google Scholar
• Lloyd-Davies K A, Rutgersson K, Sölvell L. Omeprazole in the treatment of Zollinger-Ellison syndrome, a 4-year international study. Aliment Pharmacol Ther 1988; 2: 13–32
   PubMedGoogle Scholar
• Brunner G, Creutzfeldt W, Harke U, Lamberts R. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment. Digestion 1988; 39: 80–90
   PubMed Web of Science ®Google Scholar
• Tytgat G NJ, Lamers C BHW, Wilson J A, Hameeteman W, Jansen J BMJ, Wormsley K G. 100% healing with omeprazole of peptic ulcers resistant to histamine H2-receptor antagonists. Gastroenterology 1985; 88: 1620, (abstract)
   Google Scholar
• Bardhan K D, Naesdal J, Bianchi-Porro G, et al. Treatment of refractory peptic ulcer with omeprazole. Gut 1988; 29: 724, (abstract)
   Web of Science ®Google Scholar
• Hetzel D J, Bonnin M. Long term management of hemorrhagic esophagitis with cimetidine and omeprazole. Aust NZ J Med 1986; 16: 226–228
   PubMedGoogle Scholar
• Hameeteman W, Tytgat G N. Healing of chronic Barrett ulcers with omeprazole. Am J Gastroenterol 1986; 81: 764–766
   PubMed Web of Science ®Google Scholar
• Klinkenberg-Knol E C, Meuwissen S GM. Is omeprazole effective in the treatment of patients with reflux esophagitis not responding to H2-receptor antagonists?. Gastroenterology 1987; 92: 1472, (abstract)
   Web of Science ®Google Scholar
• Klinkenberg-Knol E C, Jansen J BMJ, de Bruyne J W, et al. Longterm treatment with omeprazole (OME) in resistant reflex oesophagitis, effects on endoscopic healing and fasting serum gastrin (G) levels. Gut 1987; 28: A1379, (abstract)
   Google Scholar
• Fausa O, Aadland E, Løtveit T. Omeprazole in the treatment of patients with severe erosive oesophagitis resistant to treatment with H2-receptor antagonists. Scand J Gastroenterol 1987; 22(suppl 135)38, (abstract)
   Google Scholar
• Dent J, Klinkenberg-Knol E C, Elm G, Eriksson K, Rikner L, Solvell L. Presentation at Roma 88 International Congresses of Gastroenterology and Digestive Endoscopy
   Google Scholar
• Klinkenberg-Knol E C, Jansen J BMJ, de Bruyne J W, et al. Longterm efficacy and safety of omeprazole (OME) on healing and prevention of resistant reflux esophagitis. Gastroenterology 1988; 94: A230, (abstract)
   Google Scholar
• Meuwissen S GM, Klinkenberg-Knol E C. Treatment of reflux oesophagitis with H2-receptor antagonists. Scand J Gastroenterol 1988; 23(suppl 146)201–213
   Google Scholar
• Lieberman D A. Medical therapy for chronic reflux esophagitis. Arch Intern Med 1987; 147: 1717–1721
   PubMedGoogle Scholar
• Walsh J H, Grossman M I. Medical progress. Gastrin. N Engl J Med 1975; 292: 1324–1334
   PubMed Web of Science ®Google Scholar
• Lamberts R, Creutzfeldt W, Stockmann F, Jacubaschke U, Maas S, Brunner G. Long-term omeprazole treatment in man, effects on gastric endocrine cell populations. Digestion 1988; 39: 126–135
   PubMed Web of Science ®Google Scholar
• Gross A J, Clark V A. Survival distributions. J Wiley, New York 1975
   Google Scholar